Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (43)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Perna, A. M.
Right arrow Articles by Romano, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perna, A. M.
Right arrow Articles by Romano, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Journal of Epidemiology 2000;29:175-179
© International Epidemiological Association 2000

Antibodies to human herpes virus type 8 (HHV8) in general population and in individuals at risk for sexually transmitted diseases in Western Sicily

Anna Maria Pernaa, Filippa Bonuraa, Francesco Vitalea, Enza Vivianoa, Maria Antonella Di Benedettoa, Francesca Ajelloa, Maria Rosaria Villafratea, Tullio Prestileob, Salvatrice Mancusoc, James J Goedertd and Nino Romanoa

a Servizio di Riferimento Regionale per la diagnostica sierologica e virologica dell’AIDS, Dipartimento di Igiene e Microbiologia, Policlinico, Università di Palermo.
b Azienda Unità Sanitaria Locale 6, Presidio Ospedaliero "Casa del Sole", Palermo.
c Servizio di Riferimento Regionale per la diagnosi clinica dell’AIDS e Sindromi correlate, Policlinico, Università di Palermo.
d Viral Epidemiology Branch, National Cancer Institute, National Institute of Health, Rockville, Bethesda, Maryland, USA.

Reprint requests to: Professor Nino Romano, Dipartimento di Igiene e Microbiologia, Università degli Studi di Palermo, Policlinico, Via del Vespro,133, 90127, Palermo, Italy.

Background Human herpes virus 8 (HHV8) appears to be the primary aetiologic agent of Kaposi sarcoma (KS). To study the distribution of HHV8, a seroepidemiological study was carried out in western Sicily, where a high incidence rate of classical KS is well documented.

Methods A total of 970 sera of healthy human immunodeficiency virus (HIV) negative individuals of general population (1–70 years old) and 742 sera of individuals in different risk groups for HIV infection were evaluated by means of an indirect immunofluorescence assay able to detect antibodies to lytic and latent HHV8 antigens.

Results Crude seroprevalence to HHV8 antigens was 11.5% in the general population, and it increased significantly with age from 6% under age 16 to 22% after age 50. Significantly higher HHV8 seroprevalence rates were detected among HIV positive and negative homosexual men (62% and 22%, respectively), men who had sex with prostitutes (40% and 29%, respectively); female prostitutes (42% and 30%, respectively), and clients at a sexually transmitted disease clinic (male: 60% and 33%, respectively, female: 63% and 43%, respectively). In contrast, heterosexual intravenous drug users had seroprevalence rates comparable to those found in the general population.

Conclusions The results suggest that HHV8 infection is widespread in Western Sicily. The high seroprevalence in individuals with high risk sexual activity point to the role of sexual behaviour in the transmission of the infection in adults, whereas the detection of antibodies in younger population (under 16 years old) is suggestive of a non-sexual route of transmission, probably occurring during childhood by close personal contact.

Keywords Human herpes virus 8, antibodies, epidemiology, human immunodeficiency virus, risk groups, sexually transmitted diseases

Accepted 29 June 1999


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Int J EpidemiolHome page
E. E Brown, D. Whitby, F. Vitale, P. C. Fei, C. Del Carpio, V. Marshall, A. J Alberg, D. Serraino, A. Messina, L. Gafa, et al.
Correlates of Human Herpesvirus-8 DNA detection among adults in Italy without Kaposi sarcoma
Int. J. Epidemiol., October 1, 2005; 34(5): 1110 - 1117.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. E. Brown, M. D. Fallin, J. J. Goedert, R. Chen, D. Whitby, C. B. Foster, C. Lauria, A. J. Alberg, A. Messina, M. Montella, et al.
A Common Genetic Variant in FCGR3A-V158F and Risk of Kaposi Sarcoma Herpesvirus Infection and Classic Kaposi Sarcoma
Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 633 - 637.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Plancoulaine, L. Abel, D. Tregouet, R. Duprez, M. van Beveren, P. Tortevoye, A. Froment, and A. Gessain
Respective Roles of Serological Status and Blood Specific Antihuman Herpesvirus 8 Antibody Levels in Human Herpesvirus 8 Intrafamilial Transmission in a Highly Endemic Area
Cancer Res., December 1, 2004; 64(23): 8782 - 8787.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. J. Goedert, F. Vitale, C. Lauria, D. Serraino, M. Tamburini, M. Montella, A. Messina, E. E. Brown, G. Rezza, L. Gafa, et al.
Risk Factors for Classical Kaposi's Sarcoma
J Natl Cancer Inst, November 20, 2002; 94(22): 1712 - 1718.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
H. Hjalgrim, I. Lind, K. Rostgaard, M. Melbye, M. Frisch, A. Stossel, K. Reimann, R. J. Biggar, and D. Whitby
Prevalence of Human Herpesvirus 8 Antibodies in Young Adults in Denmark (1976-1977)
J Natl Cancer Inst, October 17, 2001; 93(20): 1569 - 1571.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.